Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

60 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Efficacy and tolerability of PTK787/ZK 222584 in a phase II study of post-transplant maintenance therapy in patients with multiple myeloma following high-dose chemotherapy and autologous stem cell transplant.
Vij R, Ansstas G, Mosley JC, Bryant G, Hassan A, Amador-Ortiz C, Procknow E. Vij R, et al. Among authors: ansstas g. Leuk Lymphoma. 2010 Aug;51(8):1577-9. doi: 10.3109/10428194.2010.488709. Leuk Lymphoma. 2010. PMID: 20528249 Clinical Trial. No abstract available.
Mutation clearance and complete radiologic resolution of immunotherapy relapsed metastatic melanoma after treatment with nivolumab and olaparib in a patient with homologous recombinant deficiency: any role for PARP inhibitors and checkpoint blockade?
Khaddour K, Ansstas M, Visconti J, Ansstas G. Khaddour K, et al. Among authors: ansstas g, ansstas m. Ann Oncol. 2021 Feb;32(2):279-280. doi: 10.1016/j.annonc.2020.10.602. Epub 2020 Dec 9. Ann Oncol. 2021. PMID: 33308899 Free article. No abstract available.
Normalization of electroretinogram and symptom resolution of melanoma-associated retinopathy with negative autoantibodies after treatment with programmed death-1 (PD-1) inhibitors for metastatic melanoma.
Khaddour K, Khanna S, Ansstas M, Jakhar I, Dahiya S, Council L, Ansstas G. Khaddour K, et al. Among authors: ansstas g, ansstas m. Cancer Immunol Immunother. 2021 Sep;70(9):2497-2502. doi: 10.1007/s00262-021-02875-x. Epub 2021 Feb 5. Cancer Immunol Immunother. 2021. PMID: 33544215 Free PMC article.
A phase II study of laser interstitial thermal therapy combined with doxorubicin in patients with recurrent glioblastoma.
Butt OH, Zhou AY, Huang J, Leidig WA, Silberstein AE, Chheda MG, Johanns TM, Ansstas G, Liu J, Talcott G, Nakiwala R, Shimony JS, Kim AH, Leuthardt EC, Tran DD, Campian JL. Butt OH, et al. Among authors: ansstas g. Neurooncol Adv. 2021 Nov 15;3(1):vdab164. doi: 10.1093/noajnl/vdab164. eCollection 2021 Jan-Dec. Neurooncol Adv. 2021. PMID: 34988450 Free PMC article.
60 results